Skip to main content
. 2020 Apr 16;60(9):1157–1165. doi: 10.1002/jcph.1610

Table 3.

Plasma Pharmacokinetic Parameters of Atogepant (Day 10 of Period 2) a

Pharmacokinetic Parameter Atogepant 60 mg Alone b
AUC0‐24h, c μmol·h/L, mean (SD) 7.92 (3.19)
Cmax, nmol/L, mean (SD) 1930 (632)
tmax, h, median (min, max) 1.5 (0.68, 2.02)

AUC0‐24h, area under plasma drug concentration‐time curve from time 0 to 24 hours; Cmax, maximum plasma drug concentration; max, maximum; min, minimum; tlast, time of last measurement; tmax, time when Cmax is reached.

a

Three participants had missing values because of early discontinuation from study.

b

Multiple oral doses of atogepant 60 mg (6 × 10‐mg tablets) once daily for 17 consecutive days, starting on day 1 of period 2.

c

AUC0‐last was used as a close approximation to AUC0‐24 (tlast range, 23.92 to 23.98 hours).